Current advances in immunotherapy for cancer

Recent advances in cancer immunotherapy, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T-cell therapy, have significantly improved the clinical management of various cancers. ICIs, such as PD-1/PD-L1 and CTLA-4 inhibitors, enhance the body's immune response agains...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Indrajit Desai, Saee Thakur, Pradeep Pagariya
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Elsevier 2024-12-01
Σειρά:	Oral Oncology Reports
Θέματα:	Checkpoint inhibitor PD-1 inhibitor PDL-1 inhibitor CTLA-4 inhibitor CAR-T cell therapy
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S2772906024004989
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!